Exact Sciences (EXAS) Tops Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. HUM
8. CSCO
9. KTOS
10. NVDA

Go back to Exact Sciences (EXAS) Tops Q2 EPS by 1c

Exact Sciences Highlights Cologuard’s® Positive Launch Trajectory in Second Quarter 2015

July 20, 2015 5:02 AM EDT

MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced its business and financial results for the second quarter of 2015, and showed continued strong performance with more than 21,000 completed Cologuard tests for the quarter, up more than 90 percent from the first quarter, which resulted in $8.1 million in revenue. Additionally, the cumulative number of ordering physicians grew to 14,700 during the quarter, a 77 percent increase.

We are pleased with Cologuards growth trajectory and that our sales and marketing strategy is driving results, said Kevin Conroy, Exact Sciences chairman and CEO. Physician and patient... More